Jiangsu Aidea Pharmaceutical Co Ltd (688488) — Net Asset Quality Index
Jiangsu Aidea Pharmaceutical Co Ltd (688488) has a Net Asset Quality Index of 52.9% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥2.06 Billion minus total liabilities of CN¥969.26 Million yields net assets of CN¥1.09 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read how much debt does Jiangsu Aidea Pharmaceutical Co Ltd carry for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Jiangsu Aidea Pharmaceutical Co Ltd Net Asset Quality Index Over Time (2016–2025)
This chart shows how Jiangsu Aidea Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 10 annual periods from 2016 to 2025. As of March 2026, the index stands at 52.9%, representing net assets of CN¥1.09 Billion against total assets of CN¥2.06 Billion CNY. For live market cap and overall valuation, see 688488 market cap.
Annual Net Asset Quality Index for Jiangsu Aidea Pharmaceutical Co Ltd (2016–2025)
The table below presents the year-by-year Net Asset Quality Index for Jiangsu Aidea Pharmaceutical Co Ltd from 2016 to 2025, covering 10 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Jiangsu Aidea Pharmaceutical Co Ltd (688488) strategic asset index to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 56.1% | CN¥1.07 Billion | CN¥1.91 Billion | CN¥839.37 Million | ▼ -1.0 pp |
| 2024 | 57.1% | CN¥1.07 Billion | CN¥1.87 Billion | CN¥802.48 Million | ▼ -7.4 pp |
| 2023 | 64.4% | CN¥1.13 Billion | CN¥1.75 Billion | CN¥621.03 Million | ▼ -8.0 pp |
| 2022 | 72.4% | CN¥1.20 Billion | CN¥1.66 Billion | CN¥456.23 Million | ▼ -18.9 pp |
| 2021 | 91.3% | CN¥1.31 Billion | CN¥1.43 Billion | CN¥124.82 Million | ▼ -2.7 pp |
| 2020 | 94.0% | CN¥1.36 Billion | CN¥1.45 Billion | CN¥86.97 Million | ▲ +22.8 pp |
| 2019 | 71.2% | CN¥556.24 Million | CN¥780.98 Million | CN¥224.74 Million | ▼ -2.5 pp |
| 2018 | 73.7% | CN¥522.71 Million | CN¥708.95 Million | CN¥186.24 Million | ▼ -4.3 pp |
| 2017 | 78.0% | CN¥514.09 Million | CN¥659.24 Million | CN¥145.14 Million | ▲ +10.3 pp |
| 2016 | 67.7% | CN¥300.40 Million | CN¥443.55 Million | CN¥143.16 Million | — |